Healio Minute Podcast, Hematology Oncology Edition: Top Headlines - Week of December 19, 2022
Click Here to Manage Email Alerts
In this edition, cancer and COVID-19 increase risk for thromboembolism, glofitamab shows curative potential in lymphoma, efgartigimod improves platelet counts, and more.
Read the full coverage here:
Biomarkers predict thromboembolism risk, mortality among people with cancer, COVID-19
Glofitamab shows ‘curative potential’ in relapsed/refractory diffuse large B-cell lymphoma
Efgartigimod confers rapid improvement in platelet counts in immune thrombocytopenia
Odronextamab ‘potentially curative’ in third-line setting for follicular lymphoma
Dana-Farber professor receives William Dameshek Prize for multiple myeloma research
References:
Broome CM, et al. Abstract 3. Presented at: ASH Annual Meeting and Exposition; Dec. 10-13, 2022; New Orleans.
Hutchings M, et al. Abstract 441. Presented at: ASH Annual Meeting and Exposition; Dec. 10-13, 2022; New Orleans.
Khorana AA, et al. Abstract 136. Presented at: ASH Annual Meeting and Exposition; Dec. 10-13, 2022; New Orleans.
Kim TM, et al. Abstract 949. Presented at: ASH Annual Meeting and Exposition; Dec. 10-13, 2022; New Orleans.
Collapse
Read more about
Click Here to Manage Email Alerts
